Related Experiment Videos
Effects of chronic morphine treatment on beta-endorphin-related peptides in the caudal medulla and spinal cord
D M Bronstein1, H B Gutstein, H Akil
1Mental Health Research Institute, University of Michigan, Ann Arbor.
Abstract:
The effects of chronic morphine treatment on beta-endorphin (beta E)-immunoreactive (beta E-ir) peptide levels were determined in the rat caudal medulla and different areas of the spinal cord. Seven days of morphine pelleting had no effect on total beta E-ir peptides in the caudal medulla. In contrast, it significantly increased beta E-ir peptide concentrations in the cervical and thoracic regions of the spinal cord compared with placebo-pelleted controls, whereas in the lumbosacral region this trend did not reach statistical significance. Injections of the opiate receptor antagonist naloxone 1 h before the rats were killed had no effect on the morphine-induced increases in the cord. Chromatographic analyses revealed that enzymatic processing of beta E-related peptides in the spinal cord seemed unaffected by the morphine and/or naloxone treatments. In light of previous data showing that morphine down-regulates beta E biosynthesis in the hypothalamus, the present results suggest that the regulation of beta E-ir peptides in the spinal cord is distinct from that found in other CNS areas. These data provide support for previous results suggesting that beta E-expressing neurons may be intrinsic to the spinal cord.
Insights
Chronic morphine treatment increases beta-endorphin (beta E) levels in the rat spinal cord, but not the caudal medulla. This suggests distinct regulation of beta E peptides in the spinal cord compared to other central nervous system areas.
Area of Science:
- Neuroscience
- Pharmacology
- Endocrinology
Background:
- Opioid peptides, such as beta-endorphin (beta E), play crucial roles in pain modulation and stress responses.
- Chronic morphine administration is known to affect endogenous opioid systems, but its impact on beta E levels in different central nervous system (CNS) regions is not fully understood.
- Previous studies suggest morphine may down-regulate beta E biosynthesis in the hypothalamus.
Purpose of the Study:
- To investigate the effects of chronic morphine treatment on beta-endorphin (beta E)-immunoreactive (beta E-ir) peptide levels in specific regions of the rat spinal cord and caudal medulla.
- To determine if spinal cord beta E regulation differs from other CNS areas.
- To assess the influence of naloxone, an opiate receptor antagonist, on morphine-induced changes in beta E levels.
Main Methods:
- Rats were treated with morphine pellets for seven days.
- Beta E-immunoreactive peptide levels were measured in the caudal medulla, cervical, thoracic, and lumbosacral spinal cord regions.
- Some rats received naloxone injections one hour before tissue collection.
- Chromatographic analyses were performed to evaluate enzymatic processing of beta E-related peptides.
Main Results:
- Chronic morphine treatment did not alter total beta E-ir peptides in the caudal medulla.
- A significant increase in beta E-ir peptide concentrations was observed in the cervical and thoracic spinal cord regions.
- The increase in beta E-ir peptides in the lumbosacral region did not reach statistical significance.
- Naloxone administration had no effect on morphine-induced increases in spinal cord beta E levels.
- Enzymatic processing of beta E-related peptides in the spinal cord appeared unaffected by morphine and/or naloxone treatments.
Conclusions:
- Spinal cord regulation of beta-endorphin (beta E)-immunoreactive peptides is distinct from that observed in other CNS areas like the hypothalamus.
- These findings support the hypothesis that beta E-expressing neurons may be intrinsic to the spinal cord.
- Chronic morphine alters beta E peptide levels in specific spinal cord segments, indicating region-specific neurochemical adaptations.